Table 2

HBeAg prevalence among HBsAg-positive females %, 2005
Region 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90-99
Asia Pacific (high income) 64.44 46.32 34.92 25.63 16.30 12.71 12.95 14.85 17.02 17.98
Central Asia 60.52 43.08 31.78 24.12 16.31 12.53 11.67 12.17 12.98 13.39
East Asia 68.72 49.16 36.10 27.31 18.35 14.01 13.00 13.53 14.51 15.05
South Asia 46.35 35.83 28.20 21.77 14.82 11.42 10.67 11.12 11.81 12.09
South East Asia 66.56 47.73 35.42 26.85 18.10 13.91 13.04 13.66 14.56 14.97
Australasia 64.00 45.86 33.89 25.64 17.38 13.49 12.61 13.08 13.92 14.34
Caribbean 58.69 43.00 31.85 24.14 16.31 12.60 11.78 12.24 13.04 13.45
Central Europe 59.04 42.85 31.91 24.21 16.33 12.55 11.73 12.29 13.13 13.51
Eastern Europe 59.18 42.97 31.87 24.15 16.34 12.64 11.75 12.17 12.89 13.23
Western Europe 63.58 41.39 29.24 22.20 15.61 12.66 12.21 12.90 13.85 14.27
Andean LA 59.42 43.02 31.77 24.08 16.27 12.52 11.70 12.27 13.16 13.54
Central LA 59.11 42.95 31.95 24.26 16.44 12.65 11.74 12.16 12.94 13.34
Southern LA 63.24 45.71 33.89 25.79 17.66 13.74 12.63 12.72 13.08 13.22
Tropical LA 59.85 43.30 31.51 24.08 17.01 13.65 12.06 11.03 10.19 9.79
North Africa and Middle East 52.12 37.62 28.09 21.60 14.98 11.73 11.02 11.41 12.03 12.34
North America (high income) 63.05 45.98 33.91 25.73 17.49 13.47 12.53 12.97 13.74 14.15
Oceania 67.25 47.89 35.66 27.09 18.32 14.11 13.24 13.80 14.53 14.84
Central Sub-Saharan Africa 54.86 40.20 29.98 22.70 15.28 11.73 11.03 11.62 12.44 12.82
East Sub-Saharan Africa 55.50 39.96 30.14 22.96 15.56 12.06 11.22 11.65 12.39 12.72
Southern Sub-Saharan Africa 54.73 36.79 26.90 21.20 15.11 11.87 11.07 11.52 12.30 12.66
West Sub-Saharan Africa 55.32 41.07 30.60 23.17 15.50 11.86 11.06 11.65 12.55 12.95

Ott et al.

Ott et al. BMC Infectious Diseases 2012 12:131   doi:10.1186/1471-2334-12-131

Open Data